, Volume 23, Issue 1–3, pp 29–38

Development of a bioartificial liver employing xenogeneic hepatocytes

  • Wei-Shou Hu
  • Julie R. Friend
  • Florence J. Wu
  • Timothy Sielaff
  • Madhusudan V. Peshwa
  • Arye Lazar
  • Scott L. Nyberg
  • Rory P. Remmel
  • Frank B. Cerra


Liver failure is a major cause of mortality. A bioartificial liver (BAL) employing isolated hepatocytes can potentially provide temporary support for liver failure patients. We have developed a bioartificial liver by entrapping hepatocytes in collagen loaded in the luminal side of a hollow fiber bioreactor. In the first phase of development, liver-specific metabolic activities of biosynthesis, biotransformation and conjugation were demonstrated. Subsequently anhepatic rabbits were used to show that rat hepatocytes continued to function after the BAL was linked to the test animal. For scale-up studies, a canine liver failure model was developed using D-galactosamine overdose. In order to secure a sufficient number of hepatocytes for large animal treatment, a collagenase perfusion protocol was established for harvesting porcine hepatocytes at high yield and viability. An instrumented bioreactor system, which included dissolved oxygen measurement, pH control, flow rate control, an oxygenator and two hollow fiber bioreactors in series, was used for these studies. An improved survival of dogs treated with the BAL was shown over the controls. In anticipated clinical applications, it is desirable to have the liver-specific activities in the BAL as high as possible. To that end, the possibility of employing hepatocyte spheroids was explored. These self-assembled spheroids formed from monolayer culture exhibited higher liver-specific functions and remained viable longer than hepatocytes in a monolayer. To ease the surface requirement for large-scale preparation of hepatocyte spheroids, we succeeded in inducing spheroid formation in stirred tank bioreactors for both rat and porcine hepatocytes. These spheroids formed in stirred tanks were shown to be morphologically and functionally indistinguishable from those formed from a monolayer. Collagen entrapment of these spheroids resulted in sustaining their liver-specific functions at higher levels even longer than those of spheroids maintained in suspension. For use in the BAL, a mixture of spheroids and dispersed hepatocytes was used to ensure a proper degree of collagen gel contraction. This mixture of spheroids and dispersed cells entrapped in the BAL was shown to sustain the high level of liver-specific functions. The possibility of employing such a BAL for improved clinical performance warrants further investigations.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abouna GM, Fischer LM, Porter KA and Andres (1973) Experience in the treatment of heptic failure by intermittent liver hemoperfursions. Surg Gynecol Obset 137, 741–752.Google Scholar
  2. Akaike T, Tobe S, Kobayashi A, Goto M and Kobayashi K (1993) Design of hepatocyte-specific extracellular matrices for hybrid artificial liver. Gastroenterol Jpn 4, 45–52.Google Scholar
  3. Busuttil TW, Colonna JO, Hiat JR, Brems JJ, el Khoury G, Goldstein LI, Quinones-Baldrich WJ, Abdul-Rasool IH and Ramming KP (1987) The first 100 liver transplants at UCLA. Ann Surg 206, 387–402.Google Scholar
  4. Chang TMS (1972) Haemoperfusions over a microencapsulated adsorbent in a patient with hepatic coma. Lancet 2, 1371–1372.Google Scholar
  5. Cima LG, Langer R and Vacanti JP (1991) Polymers for organ and tissue culture. J Bioact Compat Polymers 6, 232–240.Google Scholar
  6. Dich J, Vind C and Grunnet N (1988) Long-term culture of hepatocytes: Effect of hormones on enzyme activities and metabolic capacity. Hepatology 8, 39–45.Google Scholar
  7. Dunn J, Yarmush M, Koebe H and Tompkins R (1989) Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration. FASEB J 3, 174–177.Google Scholar
  8. Dunn J, Tompkins R and Yarmush M (1992) Hepatocytes in collagen sandwich: evidence for transcriptional and translational regulation. J Cell Biol 116, 1043–1053.Google Scholar
  9. Eiseman B, Liem DS and Raffucci F (1965) Heterologous liver perfusion in treatment of hepatic failure. Ann Surg 162, 329–345.Google Scholar
  10. Eiseman B, Norton L and Kralios NC (1976) Hepatocyte perfusion within a centrifuge. Surg Gynecol Obstet 142, 21–28.Google Scholar
  11. Fischer M, Botterman P, Sommoggy SPS and Ernhardt W (1981) 'Functional capacity of extracorporeal baboon liver perfusion', in Brunner G and Schmidt FW, Artificial Liver Support, Springer-Verlag Publications, Berlin, 280–285.Google Scholar
  12. Galletti PM (1987) Thrombosin in extracorporeal devices. Ann NY Acad Sci 516, 679–682.Google Scholar
  13. Hagar JC, Carman R, Porter LE, Stoller R, Leduc EH, Galletti PM and Calabresi P (1983) Neonatal hepatocyte culture on artificial capillaries: a model for drug metabolism and the artificial liver. ASAIO J 6, 26–35.Google Scholar
  14. Hori M, Neto AC, Austen WG and McDermott WV (1967) Isolated in vivo hepatorenal perfusion in the dog: Circulating and functional response of the kidney to hepatic anoxia. J Surg Res 7, 413–417.Google Scholar
  15. Kiley JE, Welch HF, Pender JC and Welch CS (1956) Removal of blood ammonia by hemodialysis. Proc Soc Exptl Biol and Med 91, 489–490.Google Scholar
  16. Kimoto S (1959) The artificial liver, experiments and clinical application, Transactions — American Society of Artificial Internal Organs 5, 102–112.Google Scholar
  17. Koide N, Shinji T, Tanabe T, Asano K, Kawaguchi M, Sakaguchi K, Koide Y, Mori M and Tsuji T (1989) Continued high albumin production by multicellular spheroids of adult rat hepatocytes formed in the presence of liver-derived proteoglycans. Biochem Biophys Res Commun 161, 385–391.Google Scholar
  18. Koide N, Sakaguchi K, Koide Y, Asano K, Kawaguchi M, Matsushima H, Takenami T, Shinji T, Mori M and Tsuji T (1990) Formation of multicellular spheroids composed of adult rat hepatocytes in dishes with positively charged surfaces and under other nonadherent environments. Exp Cell Res 186, 227–35.Google Scholar
  19. Lanford RE, Carey KD, Estlack LE, Smith GC and Hay RV (1989) Analysis of plasma protein and lipoprotein synthesis in long-term primary cultures of baboon hepatocytes maintained in serum-free medium. In Vitro Cell and Develop Biol 25, 174–182.Google Scholar
  20. Lazar A, Madhusudan PV, WU Fj, Chi CM, Cerra FB and Hu W-S (1995) Formation of porcine hepatocyte spheroids for use in a bioartificial liver. Cell Transplant 4, 259–268.Google Scholar
  21. Lazar A, Mann HJ, Remmel RP, Shatford RA, Cerra FB, Hu W-S (1995) Extended liver-specific functions of porcine hepatocyte spheroids entrapped in collagen gel. In Vitro Cell Develop 31, 340–346.Google Scholar
  22. Lie TS (1981), 'Treatment of acute hepatic failure by extracorporeal hemoperfusion over human and baboon liver', in Brunner G and Schmidt FW, Artificial Liver Support, Springer-Verlag Publications, Berlin, 274–279.Google Scholar
  23. Matsumara K (1973) Method and device for purifying blood, U.S. Patent No. 3734851, U.S. Patent Office, Washington, D.C.Google Scholar
  24. Matsumara KN, Guevara GR, Huston H, Hamilton WL, Rikimaru M, Yamasaki G and Matsumara MS (1987) Hybrid bioartificial liver in hepatic failure: preliminary clinical report. Surgery 101, 99–103.Google Scholar
  25. Mikos AG, Bao Y, Cima LG, Ingber DE, Vacanti JP and Langer R (1993) Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. J Biomed Mat Res 27, 183–189.Google Scholar
  26. National Center for Health Statistics (1991) Briths, Marriages, Divorces and Deaths for 1990, Monthly Vital Statistics Report, 39, 1–14.Google Scholar
  27. Neuzil D, Rozga J, Moscioni A, Ro M, Hakim R and Demetriou A (1991) Use of a xenogeneic liver support system to treat a patient with acute liver failure. Hepatology 14, 246A.Google Scholar
  28. Norman JC, Saravis CA,, Brown ME and McDermott WVJ (1966) Immunological observations in clinical heterologous (xenogeneic) liver perfusions. Surgery 60, 179–190.Google Scholar
  29. Nose Y, Mikami J, Kasai K, Sasaki E, Agishi T and Danjo Y (1963) An experimental artificial liver utilizing extracorporeal metabolism with sliced or granulated canine liver. Trans Am Soc Artif Intern Organs 9, 358–362.Google Scholar
  30. Nyberg Sl, Shatford RA, Payne W, Hu WS, Cerra FB (1992) Hepatocyte culture systems for artificial liver supprot: implications for critical care medicine (bioartificial liver support). Crit Care Med 20, 1157–1168.Google Scholar
  31. Nyberg SL, Shatford R, Peshwa MW, White JG, Cerra FB and Hu W-S (1993) Evaluation of a hepatocyte entrapment hollow fiber bioreactor: a potential bioartificial liver. Biotechnol Bioeng 41, 194–203.Google Scholar
  32. Nyberg SL, Shirabe K, Peshwa M, Sielaff TD, Crotty PL, Mann HJ, remmel RP, Payne WD, Hu W-S and Cerra FB (1993) Extracorporeal application of a gel-entrapment, bioartificial liver: demonstration of drug metabolism and other biochemical functions. Cell Transplantation 2, 441–452.Google Scholar
  33. Nyberg SL, Payne WD, Amiot B, Shirabe K, Remmel RP, Hu W-S and Cerra FB (1993) Demonstration of biochemical function by extracorporeal xeno-hepatocytes in an anhepatic animal model. Transplant Proc 25, 1944–1945.Google Scholar
  34. Nyberg SL, Mann HJ, Hu MY, Payn WD, Cerra FB, Remmel RP and Hu W-S (1996) Extrahepatic metabolism of 4-methylumbelliferone and lidocaine in the anhepatic rabbit. Drug Metabolism and Disposition 24, 643–648.Google Scholar
  35. Opolon P, Rapin JR, Huguet C, Granger A, Delorme ML, Boschat M and Sausse A (1976) Hepatic failure coma treated by poly-acrylonitrile membrane hemodialysis. Trans Am Soc Artif Intern Organs 22, 701–710.Google Scholar
  36. Otto JJ, Pender JC, Cleary JH, Sensening DM and Welch DS (1958) The use of a donor liver in experimental animals with elevated blood ammonia. Surgery 43, 301–309.Google Scholar
  37. Peleman RR, Gavaler JS, van Thiel DH, Esquivel C, Gordon R, Iwatsuki S and Starzl TE (1987) Orthotopic liver transplantation for acute and subacute hepatic failure in adults. Hepatology 7, 484–489.Google Scholar
  38. Peshwa MV, Wu FJ, Follstad BD, Cerra FB and Hu W-S (1994) Kinetics of formation of hepatocyte spheroids. Biotechnol Prog, Accepted April 14, 1994.Google Scholar
  39. Peshwa MV, Wu FJ, Sharp HL, Cerra FB and Hu W-S (1994) Mechanistics of formation and ultrastructural evaluation of hepatocyte spheroids. In Vitro Cell and Develop Biol, submitted.Google Scholar
  40. Peshwa MV, Wu FJ, Follstad BD, Cerra FB and Hu W-S (1994) Kinetics of hepatocyte spheroid formation. Biotechnol Prog 10, 460–466.Google Scholar
  41. Peshwa MV, Wu FJ, Sharp HL, Cerra FB and Hu W-S (1996) Mechanistics of formation and ultrastructural evaluation of hepatocyte spheroids. In Vitro Cell Develop 32, 197–203.Google Scholar
  42. Schechter DC, Nealon TF and Gibbon JH (1958) A simple extracorporeal device for dreducing elevated blood ammonia levels. Surgery 44, 892–897.Google Scholar
  43. Sielaff TD, Hu MY, Rao S, Groehler K, Olson D, Amiot B and Hu W-S (1995) A technique for porcine hepatocyte harvest and description of differentiated metabolic functions in static culture. Transplantation 59, 1459–63.Google Scholar
  44. Sielaff TD, Hu MY, Amiot B, Rollins MD, Rao S, McGuire B, Bloomer JR, Hu W-S and Cerra FB (1995) Gel-entrapment bioartificial liver therapy in galactosamine hepatitis. J Surg Res 59, 179–184.Google Scholar
  45. Sielaff TD, Hu MY, Rollins M, Bloomer JR, Amiot B, Hu W-S and Cerra FB (1995) An anesthetized model of lethal canine galactosamine fulminant hepatic failure. Hepatology 21, 796–804.Google Scholar
  46. Shatford RA, Nyberg SL, Payne WD, Hu W-S and Cerra FB (1991) Hepatocyte function in a hollow fiber bioreactor: a potential bioartificial liver. J Surg Res 53, 549–557.Google Scholar
  47. Shatford RA, Nyberg SL, Payne WD, Hu W-S and Cerra FB (1991) A hepatocyte bioreactor as a potential bioartificial liver: demonstration of prolonged tissue specific functions. Surgical Forum 42, 54–56.Google Scholar
  48. Shimaoka S, Nakamura T and Ichihara A (1987) Stimulation of growth of primary cultured adult rat hepatocytes without growth factors by coculture with nonparenchymal liver cells. Exp Cell Res 172, 228–242.Google Scholar
  49. Spray DC, Fujita M, Saez J, Choi H, Watanabe T. Hertzberg E, Rosenberg L and Reid L (1987) Proteoglycans and glycosaminoglycans induce gap junction synthesis and function in primary liver cultures. J Cell Biol 105, 541–551.Google Scholar
  50. Starzl TE, Demetris Aj and van Thiel D (1989) Liver transplantation (1). New Engl J Med 321, 1092–1099.Google Scholar
  51. Takahashi T, Malchesky PS and Nose Y (1991) Artificial liver. State of the art. Dig Dis Sci 36, 1327–1340.Google Scholar
  52. Ton HY, Hughes RD, Silk DBA and Williams R (1979) Albumin coated Amberlite XAD-7 resin for hemoperfusion in acute liver failure. Part I: Adsorption studies. Artif Organs 3, 20–22.Google Scholar
  53. Tong, JZ, De LP, Furlan V, Cresteil T, Bernard O and Alvarez F (1992) Long-term culture of adult rat hepatocyte spheroids. Exp Cell Res 200, 326–332.Google Scholar
  54. Vacanti JP, Lillehei CW, Jenkins RL, Donahoe PK, Cosimi AB, Kleinman R, Grand RJ and Cho SI (1987) Liver transplantation in children: The Boston Center experience in the first 30 months. Transplant Proc 19, 3261–3266.Google Scholar
  55. Vacanti JP, Morse MA, Saltzman WM, Domb AJ, Perez-Atayde A and Langer R (1988) Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg 23, 3–9.Google Scholar
  56. Wu FJ, Peshwa MV, Cerra FB and Hu W-S (1995) Entrapment of hepatocyte spheroids in a hollow fiber bioreactor as a potential bioartificial liver. Tissue Eng 1, 29–40.Google Scholar
  57. Wu FJ, Friend JR, Hsiao CC, Zilliox MJ, Ko WJ, Cerra FB and Hu W-S (1996) Efficient assembly of rat hepatocyte spheroids for tissue engineering applications. Biotechnol Bioeng 50, 404–415.Google Scholar
  58. Wu FJ, Friend JR, Lazar A, Mann HJ, Remmel RP, Cerra FB and Hu WS (1996) Hollow fiber bioartificial liver utilizing collagen entrapped porcine hepatocyte spheroids. Biotechnol Bioeng 52, 34–44.Google Scholar
  59. Yamamoto N, Imazato K and Matsumoto A (1989) Growth stimulation of adult rat hepatocytes in a primary culture by soluble factor(s) secreted from nonparenchymal liver cells. Cell Struct Funct 14, 217–229.Google Scholar
  60. Yatzidis H (1964) A convenient hemoperfusion microapparatus over charcoal for the treatment of endogeneous and exogeneous intoxications: Its use as an effective artificial kidney. Proc Eur Dial Transplant Assoc 1, 83–87.Google Scholar

Copyright information

© Kluwer Academic Publishers 1997

Authors and Affiliations

  • Wei-Shou Hu
    • 1
  • Julie R. Friend
    • 1
  • Florence J. Wu
    • 1
  • Timothy Sielaff
    • 1
  • Madhusudan V. Peshwa
    • 1
  • Arye Lazar
    • 1
  • Scott L. Nyberg
    • 1
    • 2
  • Rory P. Remmel
    • 3
  • Frank B. Cerra
    • 2
  1. 1.Departments of Chemical Engineering and Materials ScienceUniversity of MinnesotaMinneapolis
  2. 2.Department of SurgeryUniversity of MinnesotaMinneapolis
  3. 3.Department of Medicinal ChemistryUniversity of MinnesotaMinneapolis

Personalised recommendations